The latest update is out from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ).
Fisher & Paykel Healthcare has launched the F&P Nova Nasal mask in New Zealand and Australia, expanding its portfolio for treating obstructive sleep apnea. The mask features innovative technology aimed at enhancing patient comfort and improving treatment outcomes, with positive clinical trial results supporting its effectiveness. This launch reinforces the company’s leadership in mask innovation and its commitment to meeting the needs of patients and business partners globally.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare is a prominent designer, manufacturer, and marketer of products and systems for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment, with a global presence in over 120 countries.
YTD Price Performance: -32.54%
Average Trading Volume: 369
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.68B
See more insights into FSPKF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com